Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.
Richard Hague, insider at PolarityTE

Richard Hague Insider Information

Insider of PolarityTE
Richard Hague is an accomplished senior biotechnology executive with extensive commercial, operations and general management experience with both small and large cap, private and public companies. Before joining PolarityTE, Richard was the Chief Commercial Officer at Anika Therapeutics, where he oversaw all global commercial activities, as well as the R&D and Clinical Research functions. Anika has a hyaluronic acid based technology platform used in orthopedics, wound care and ophthalmology.  Prior to his tenure with Anika, Richard was Vice President of Sales and Marketing at TEI Medical, the manufacturer of a bioengineered dermal scaffold used in the treatment of complex wounds, which was later acquired by Integra. Richard spent a significant portion of his career at Genzyme and later Sanofi (post Sanofi's acquisition of Genzyme) where he held positions of increasing responsibility, culminating in his role as VP/General Manager of Sanofi’s Cell Therapy and Regenerative Medicine Business Unit. While at Genzyme, Richard was involved in the launch of the first autologous cell therapy product that ultimately led to FDA’s establishment of the BLA regulatory pathway.  Subsequently, he has led successful launches of innovative products in the biologics, small molecule and medical device arenas.

What is Richard Hague's net worth?

The estimated net worth of Richard Hague is at least $1.88 million as of July 19th, 2021. Mr. Hague owns 801,581 shares of PolarityTE stock worth more than $1,883,715 as of May 22nd. This net worth approximation does not reflect any other investments that Mr. Hague may own. Additionally, Mr. Hague receives an annual salary of $649,260.00 as Insider at PolarityTE. Learn More about Richard Hague's net worth.

How old is Richard Hague?

Mr. Hague is currently 62 years old. There are 4 older executives and no younger executives at PolarityTE. Learn More on Richard Hague's age.

What is Richard Hague's salary?

As the Insider of PolarityTE, Inc., Mr. Hague earns $649,260.00 per year. Learn More on Richard Hague's salary.

How do I contact Richard Hague?

The corporate mailing address for Mr. Hague and other PolarityTE executives is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. PolarityTE can also be reached via phone at (800) 560-3983 and via email at [email protected]e.com. Learn More on Richard Hague's contact information.

Has Richard Hague been buying or selling shares of PolarityTE?

Richard Hague has not been actively trading shares of PolarityTE during the past quarter. As far as recent transactions, on Sunday, May 22nd, 0 shares of BMO Capital Markets stock. Learn More on Richard Hague's trading history.

Who are PolarityTE's active insiders?

PolarityTE's insider roster includes Richard Hague (Insider), and David Seaburg (CEO). Learn More on PolarityTE's active insiders.

Are insiders buying or selling shares of PolarityTE?

In the last twelve months, insiders at the sold shares 4 times. They sold a total of 80,980 shares worth more than $54,486.29. The most recent insider tranaction occured on October, 19th when Director David B Seaburg sold 31,037 shares worth more than $17,070.35. Insiders at PolarityTE own 5.4 % of the company. Learn More about insider trades at PolarityTE.

Information on this page was last updated on 10/19/2021.

Richard Hague Insider Trading History at PolarityTE

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/19/2021Sell12,600$0.71$8,946.00801,581View SEC Filing Icon  
6/29/2021Sell6,311$1.02$6,437.22805,241View SEC Filing Icon  
2/7/2020Sell12,950$3.02$39,109.00321,895View SEC Filing Icon  
10/28/2019Sell2,402$2.71$6,509.42
10/11/2019Sell3,885$3.07$11,926.95
9/27/2019Sell2,402$3.56$8,551.12
See Full Table

Richard Hague Buying and Selling Activity at PolarityTE

This chart shows Richard Hague's buying and selling at PolarityTE by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PolarityTE Company Overview

PolarityTE logo
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $2.35
Low: $2.32
High: $2.95

50 Day Range

MA: $7.15
Low: $2.35
High: $74.25

2 Week Range

Now: $2.35
Low: $2.32
High: $29.50

Volume

265,605 shs

Average Volume

316,428 shs

Market Capitalization

$9.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.13
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.